Market Watch

U.S. Oil Rig Count Extends Advance

U.S. Oil Rig Count Extends Advance

April 21, 2017 at 1:21 pm 0 comments

The number of oil rigs operating in the U.S. rose by five to 688, climbing for the 14th consecutive week to the highest level since April. 4, 2015, according to data from energy services firm Baker Hughes (BHI), which tracked the seven-day period ended April 21. In the U.S., the combined oil and gas rigs count increased by 10 toRead More

Middle East Stocks Mostly Lower

Middle East Stocks Mostly Lower

April 20, 2017 at 11:43 am 0 comments

Middle East shares mostly dropped on Q1 results and profit-taking. Saudi Arabia was also weighed by a slump in oil prices. In company news, Abu Dhabi National Energy Co’s COO told Reuters it might sell some oil and gas interests in North America to raise capital for core businesses. First Abu Dhabi Bank said Q1 combined proforma net profit roseRead More

Asian ADRs Shift Lower

Asian ADRs Shift Lower

April 18, 2017 at 11:46 am 0 comments

American depository receipts of Asian stocks were trading 0.66% lower at 149.59 on the Bank of New York Mellon Asia ADR Index on Tuesday. In North Asia, the gainers were led by online game publisher The9 (NCTY), and solar equipment maker SPI Energy (SPI), which rose 3.7% and 3.5% respectively. They were followed by aluminum producer Aluminum Corporation of ChinaRead More

Frontier Communications Renews Content Distribution Deal with EPIX

Frontier Communications Renews Content Distribution Deal with EPIX

April 17, 2017 at 12:09 pm 0 comments

Entertainment network EPIX said Monday that it has renewed its distribution agreement under it provides Frontier Communications (FTR) customers with access to its entertainment content. Terms of the agreement were not disclosed. Metro-Goldwyn-Mayer announced earlier this month that it will acquire full ownership of EPIX, having reached an agreement to acquire the interests held by joint venture partners Viacom (VIA),Read More

Anthera Pharmaceuticals Completes Dosing in Phase 2

Anthera Pharmaceuticals Completes Dosing in Phase 2

April 10, 2017 at 11:31 am 0 comments

Anthera Pharmaceuticals has completed patient dosing in its randomized, double-blind, placebo controlled, phase 2 BRIGHT-SC study of blisibimod in patients with IgA nephropathy (IgAN), the company said Monday. Shares were up 8.7% or three cents in recent pre-market trade. IgA nephropathy (IgAN, also known as Berger’s disease) is the most common cause of primary glomerulonephritis worldwide, occurring more frequently inRead More

Visa Says Checkout Service Reaches Milestone

Visa Says Checkout Service Reaches Milestone

April 6, 2017 at 11:47 am 0 comments

Visa shares were slightly lower Thursday morning after the credit card company said its Visa Checkout service reached a milestone of more than 20 million enrolled customers. Visa Checkout is a service that enables consumers to pay on any internet-connected device with some of the world’s top merchants, the company noted. Visa also said that Visa Checkout will continue toRead More

Diffusion Pharma Secures U.S. Patent

Diffusion Pharma Secures U.S. Patent

April 4, 2017 at 10:58 am 0 comments

Diffusion Pharmaceuticals gained in premarket trading after the clinical stage biotechnology company, said a key patent has been issued by the U.S. Patent and Trademark Office (USPTO) for its lead drug candidate trans sodium crocetinate (TSC). Shares rose as much as 25%. The U.S. patent was entitled “Bipolar Trans Carotenoid Salts and Their Uses.” It expands coverage of the therapeuticRead More